Pioneers in Plasma Surgery & Medicine - Over 80,000 Procedures & Counting

Contact Us
Support
Careers

About Us
Products
Sciences & Technology
Clinical Specialties
Media Center
CLINICAL TRIAL
Login

Home
About Us
Products
Sciences & Technology
Clinical Specialties
Media Center
CLINICAL TRIAL
Contact Us
Support
Careers

COLD PLASMA ONCOTHERAPEUTICS

JCRI INTRODUCES:

CANADY COLD PLASMA GENERATED EXOSOME IMMUNOTHERAPY

Pre-Clinical Phase

CANADY COLD PLASMA FOR THE TREATMENT OF CANCER

Clinical Phase

2024 © US Medical Innovations | v 2.1.001

Canady Biotechnology proudly manufacture our products in the USA
Keep America Strong

1. Pre-Operative Phase: Patient Diagnosed with Soild Tumor

2. Pre-Operative Phase: Standard Treatment Protocol - Radiation and/or Chemotherapy

3A & 3B. Intra-Operative Phase

4. Post-Operative Follow-up: Chemotherapy (3-5 +/- Cycles)

Cold Plasma Generated Exosome Immunotherapy

Using Canady Cold Plasma for Individualized Targeted Medicine

1. Harvest Cancer Cells from the Patient’s Solid Tumors

2. Isolate the Patient’s Tumor Cells

3. Spray Tumor Cells with Canady Cold Plasma to treat the cells, and release a higher yield of Programmed Exosomes.

4. Collect and Process the Programmed Exosomes

5. Infuse the Programmed Exosomes back into the Patient to Attack and Kill Distant Cancer Cells...

6. Targeted Tumor Cell Death from Programmed Exosomes